“abilify” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
Alkermes CEO Richard Pops on Building Big, Playing Well with Pharma 04/18/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds 01/03/13 Boston
Ex-Pfizer Exec Ed Harrigan Takes Top Job at Secretive Karuna Pharmaceuticals 01/20/11 Boston
Life Sciences Discovery Fund Debunks Perceptions with Omeros Deal, Shows State Can Bankroll Companies 12/14/10 Seattle
Alkermes CEO Leans on Internal Pipeline as Bydureon Hangs Out in the Penalty Box 11/15/10 Boston
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets 10/25/10 Seattle
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge 10/14/10 Boston
Alkermes Reveals Higher-Than-Expected Royalty on Diabetes Drug 04/26/10 Boston
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood 02/04/10 Boston
Why Aren’t There Good Drugs for Autism? Ex-MDRNA Exec Takes a Shot at Pharma’s Neglected Disease 09/14/09 Seattle
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease 09/04/08 Seattle
Page 1 of 1